Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta‑analysis

  • Authors:
    • Muyun Wu
    • Shujing Huang
    • Dong Liu
    • Miao Peng
    • Fan Yang
    • Xicheng Wang
  • View Affiliations

  • Published online on: December 8, 2015     https://doi.org/10.3892/mco.2015.700
  • Pages: 221-228
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

p53 and glutathione S‑transferase M1 (GSTM1) are the most popular suppressor genes. Several previous studies demonstrated positive associations of these gene polymorphisms with numerous cancer types, including hepatocellular cancer, while the association between p53/GSTM1 polymorphisms and the nasopharyngeal carcinoma (NPC) risk was inconsistent and underpowered. However, no studies investigating the combinational effect of these two genes on NPC risk were performed. To confirm the effects of p53 and GSTM1 polymorphisms on the risk of NPC, a meta‑analysis of all the available previous studies associating p53 and GSTM1 with the risk of NPC was performed. A comprehensive search of PubMed, Web of Science and SD database until November 2014 was performed to identify the relevant studies. The data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Meta‑regression and subgroup analyses were performed to identify the source of heterogeneity. Finally, five studies with 1,419 cases and 1,707 controls were included for the p53 polymorphism and three studies with 837 cases and 1,299 controls were included for the GSTM1 polymorphism. Regarding p53, a significantly increased NPC risk was observed in the overall population (C vs. G, OR, 1.245; 95% CI, 1.045‑1.483; P=0.014; additive models: CC vs. GG, OR, 1.579; 95% CI, 1.100‑2.265; P=0.013 and CG vs. GG, OR, 1.230; 95% CI, 1.039‑1.456; P=0.016; dominant model, OR, 1.321; 95% CI, 1.127‑1.549; P=0.001; recessive model, OR, 1.429; 95% CI, 1.017‑2.009; P=0.040). Concerning GSTM1, a significantly increased NPC risk was observed in the overall population (null versus non‑null, OR, 1.282; 95% CI, 1.075‑1.530; P=0.006). In the subgroup analyses stratified by the source of controls, a significant association of p53 with NPC risk was also demonstrated, while no association with GSTM1 was observed. Therefore, the p53 G72C polymorphism may have a susceptible role in the carcinogenesis of NPC, while genetic deletion of GSTM1 may contribute to increased susceptibility to NPC. Further large and well‑designed studies are required to confirm this association.
View Figures
View References

Related Articles

Journal Cover

February 2016
Volume 4 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wu, M., Huang, S., Liu, D., Peng, M., Yang, F., & Wang, X. (2016). Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta‑analysis. Molecular and Clinical Oncology, 4, 221-228. https://doi.org/10.3892/mco.2015.700
MLA
Wu, M., Huang, S., Liu, D., Peng, M., Yang, F., Wang, X."Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta‑analysis". Molecular and Clinical Oncology 4.2 (2016): 221-228.
Chicago
Wu, M., Huang, S., Liu, D., Peng, M., Yang, F., Wang, X."Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta‑analysis". Molecular and Clinical Oncology 4, no. 2 (2016): 221-228. https://doi.org/10.3892/mco.2015.700